The human origin of a laboratory enzyme preparation does not turn the whole experiment into a human clinical study.
Triphala inhibited several CYP reactions in human liver microsomes, including CYP3A4. Separate rat experiments found increased oral midazolam bioavailability with the tested extract. The investigators did not find a comparable P-glycoprotein effect in the selected cell assay.
The oral extract dose, composition and species differ from typical human use. Laboratory inhibition and rat exposure changes cannot quantify a patient interaction. Negative findings in one transporter assay do not exclude every distribution or absorption mechanism.
For a supplement-related opinion, identify the actual product and evidence level at each step. Separate preparation-specific inhibition from observed human exposure. The source supports an interaction hypothesis, not a universal prediction that Triphala increases benzodiazepine concentrations by the same percentage in people.
Source reviewed: Inhibitory effects of Triphala on CYP isoforms in vitro and its pharmacokinetic interactions with ph (PMC9243172). Forensic applications above are interpretive analysis of the supplied publication.
Related reading: Basmisanil’s Rat Memory Effects and Human Target Engagement Were Different Evidence Streams.